Close
Help


Blastic Plasmacytoid Dendritic Cell Neoplasm

Posted Thu, Dec, 19,2013

Published today in Clinical Medicine Insights: Case Reports is a new case report article by Lindsey Prochaska, Christopher Dakhil and Sharad Mathur.  Read more about this paper below:

Title

Blastic Plasmacytoid Dendritic Cell Neoplasm

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive myeloid neoplasm derived from plasmacytoid monocytes. The most common presentation involves cutaneous manifestations, which are often accompanied by bone marrow involvement. The tumor cells reveal an immature blastic appearance and diagnosis is based on the expression of cluster of differentiation (CD)4 and CD56. The literature reports a high relapse rate and poor prognosis when treated with leukemia-type induction chemotherapy alone; however, long-term remission is attainable with allogeneic stem cell transplantation in the first complete remission. Here, we report the dismal course of a patient with BPDCN with cutaneous and bone marrow involvement unable to undergo an aggressive intervention.

Click here to learn more about the article, download it and comment

share on

Posted in: Articles Published

  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors
What Your Colleagues Say About Libertas Academica
I found that publishing my paper in Signal Transduction Insights was a very satisfying experience. The submission process was simple, review rapid and thorough and the appearance of the article was first rate. I recommend this journal.
Dr Stuart K Calderwood (Beth Israel Deaconess Medical Center Boston, Massachusetts, USA)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube